ORA Research News - Monday, August 5, 2019
DEADLINE UPDATE: IBEST-OUHSC Funding for Interdisciplinary Research – Request for Applications to
support collaborative research activities between OUHSC researchers and OU-Norman researchers in the area of
biomedical engineering - Deadline September 6, 2019 – please see guidelines and face page attached.
COGR and the Health Research Alliance (HRA) invite you to save-the-date on September 24, 2019 for a day-long
workshop of the Nonprofit Funder – Research Institution (NFRI) Partnership. The workshop will facilitate
ongoing discussions and efforts around four key elements of foundation-institution relations: (1) Streamlining
administrative requirements; (2) Indirect costs/research project support costs; (3) Intellectual property and tech transfer
issues; and (4) overall principles for successful partnerships between nonprofit funders and research institutions. This
is the fourth in-person NFRI partnership meeting. Additional information on the history of the partnership and presentations
and materials from previous meetings can be found at https://www.cogr.edu/nonprofit-funder-research-institution-partnership.
The draft agenda for the September 24 meeting can be found at the website above and registration will be opening soon.
The location of the workshop is the American Association for the Advancement of Science (AAAS) Building, located at
1200 New York Ave, Washington, DC 20005 (also home to COGR). AAAS headquarters are one block from the
Washington metro’s Metro Center station, which services the red, orange, blue and silver lines, and a 10-15 minute walk
from Gallery Place (serving the yellow and green metro lines). It’s recommended that you make your hotel reservations
early as this area books up quickly.
NIH issued a notice yesterday delaying the requirement for institutions to report the results of basic research on human
studies in ClinicalTrials.gov until September 2021. The delay applies only to basic experimental studies with humans
(BESH) studies submitted to funding opportunities designated as “basic experimental studies with humans” in the title.
Applicants must identify alternative platforms for reporting the research results and include the information in the
Dissemination Plan attachment of the application.
In a November 2018 letter, COGR, many other organizations, and many of our member institutions strongly urged the
NIH to separate the reporting of clinical trial studies from basic research and consider a more appropriate reporting
mechanism for basic research studies.
See the full notice at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-126.html
Contact Information: Michelle D. Christy
Council on Governmental Relations
1200 New York Ave NW Suite 460
Washington DC 20005
Executive Order 13861 (https://www.whitehouse.gov/presidential-actions/executive-order-national-roadmap-empower-veterans-end-suicide/)
the President’s Roadmap to Empower Veterans and End a National Tragedy of Suicide (PREVENTS) was
signed March 5, 2019. VA is pleased that this EO effort is led by an inter-agency Cabinet-level Task Force and Dr. Barbara
Van Dahlen as the Executive Director. The goal of the Task Force is to create a Roadmap that will reduce suicide by
empowering veterans to pursue an improved quality of life, prioritizing research, and establishing collaboration across the
public and private sectors. The Roadmap will utilize a public health approach with the goal of changing the culture of how
veteran suicide is approached, discussed and prevented. It will be a comprehensive plan building on existing efforts from each
agency and office that is represented on the Task Force. It also intends to reach out across all communities collaborating
under this EO. For additional information see the attached document.
PRESBYTERIAN HEALTH FOUNDATION GRANTS – REQUEST FOR APPLICATIONS – CYCLE II BRIDGE GRANTS
Bridge Grant Program – DUE DATE AUGUST 16, 2019 (REVISED GUIDELINES)
The primary objective of the PHF Bridge Grant program is to provide funding to enhance OUHSC faculty competitiveness for
extramural funding. OUHSC Principal Investigators who have submitted an extramural application that was scored but not
funded within the past 18 months and is requesting over $750,000 in total direct costs and over $200,000 in total facilities and
administration (F&A) costs and received a review that ranks applications and provides critiques are eligible. This program can
provide funding for up to $75,000 for one year. Guidelines and Application Form is attached or can be found at:
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Bridge Grant Guidelines - August 16 2019.docx?ver=2019-07-16-080651-860
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Pilot Projects in Diabetes CoBRE flyer 2019.pdf?ver=2019-07-22-082134-707
The Diabetes CoBRE Program at OUHSC intends to support pilot projects. The goal is to provide seed funds to
support projects that have the potential to receive NIH funding in the future. Any investigator working in the state of Oklahoma
who meets the requirements defined below, and who has a project related to diabetes or diabetic complications, is welcome to
apply. The application deadline is 5pm, August 16, 2019. Funding starts by October 1, 2019.
See the attached document and go to: http://www.ouhsc.edu/odc/CoBRE/index.asp
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Pilot Projects in Diabetes CoBRE flyer 2019.pdf?ver=2019-07-22-082134-707
The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical and Translational Resources
(OSCTR) is soliciting applications for its Clinical and Translational Research Pilot (CTRP) Grants Program and its Community
Engaged Research Exploratory Awards.
Oklahoma Shared Clinical and Translational Resources Clinical and Translational Research Pilot (CTRP) Grants
The purpose of the program is to provide funding for collaborative and/or multi-disciplinary clinical and translational pilot projects
between investigators of the OSCTR member institutions. The program seeks to support proposals designed to generate preliminary
data that will result in improved health and/or healthcare for citizens of Oklahoma and other IDeA states and enhance the
competitiveness of the investigators for future extramural funding. The program also seeks to fund innovative concepts, approaches,
and methodologies that bring fresh new ideas to solving the health issues of those living in Oklahoma and collaborating IDeA states.
Projects that focus on the medically underserved and on health concerns prevalent within Oklahoma and our OSCTR partners will
be a priority. Only projects which meet the NIH definition of clinical and/or translational research will be accepted.
Approved CTRP grants will be funded for a period starting January 1, 2020 contingent on NIH approval of just in time (JIT) information.
All funds are required to be expended by December 31, 2020.
The forms, instructions, and submission link can be found at: http://osctr.ouhsc.edu/pilots2019
Deadlines for submission: Pilot Proposal – Friday, August 9, 2019 at 5:00 PM CDT
Oklahoma Shared Clinical and Translational Resources Community-Engaged Research Exploratory (CERE) Awards
This program is intended to support community engagement to develop funded research partnerships. Funds can be used for research
development activities, including convening partners, working with individuals pursuing related work, and conducting needs assessments
in community settings. The funds cannot be used to support actual human-subjects research protocols, which can be funded under other
OSCTR pilot research programs and/or external funding.
The application should consist of a 2-page letter from the main applicant (which can be either a community agency or an academic
researcher) describing the collaboration, the contributions that the proposed work will make to a successful research partnership, and a
line item budget. Budget requests are expected to be $5,000-$10,000 with budgets that permit the expenditure of the entire award by
June 30, 2020. A separate letter of support from either the academic or community partner indicating their agreement with the proposed
activities should also be included. Proposals will be evaluated on a rolling basis beginning July 1, 2019. Please submit proposals by
email to email@example.com.
Interested applicants can discuss their proposal, eligibility, allowable budget items, and available funding by contacting the OSCTR
staff at firstname.lastname@example.org or call 405-271-3480.
OSCTR TPIR Trainee Program
Seeking applicants for the sixth year of the research training program Translating Practice into
Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, and basic
Scientists and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal
of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to
translate their clinical observations and ideas for improving practice into practical and feasible research
projects. Attached is a detailed description and application due September 3, 2019.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/OSCTR CERE Instructions 2019.pdf?ver=2019-07-01-074315-177
Harold Hamm Diabetes Center (HHDC) - Please mark your calendar for the 16th Annual Harold Hamm
Diabetes Center Research Symposium. This event will be held on Friday, November 15, 2019 at the Samis Education Center at
Children’s Hospital in Oklahoma City. Deadline for abstracts will be announced later this summer. Additional details will be posted on
http://haroldhamm.org/ Questions? Please email
Extension of Certain Flexibilities for Prospective Basic Experimental Studies With Human Participants
Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research (NOT-OD-19-128)
Notice of Informational Webinar for PAR-19-301 Limited Competition: NIGMS National and Regional Resources
(R24 Clinical Trial Not Allowed) (NOT-GM-19-053)
Consolidated Notice on NIMH Clinical Trials Policies (NOT-MH-19-031)
Registration Open for the ICARE Academy on September 10-11, 2019, in Alexandria, VA (NOT-OD-19-123)
Notice of System Change and Procedure for Requesting an Extension to Early Stage Investigator (ESI)
Request for Information (RFI): Swallowable Smart Pills or Devices to Enable Precision Nutrition, Microbiome and
Gastroenterological Research (NOT-DK-19-020)
Notice of Correction to PAR-19-314 "NIA Program Project Applications (P01 Clinical Trial Optional)"
Notice of Clarification to PAR-18-841, "Oncology Co-Clinical Imaging Research Resources to Encourage Consensus
on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)"
Notice of Clarification of Program Director/Principal Investigator Eligibility for PAR-19-102 Graduate Research
Training Initiative for Student Enhancement (G-RISE) (T32) (NOT-GM-19-050)
Notice of Clarification of Program Director/Principal Investigator Eligibility for PAR-19-218 Undergraduate Research
Training Initiative for Student Enhancement (U-RISE) (T34) (NOT-GM-19-051)
Notice of Clarification of Eligibility for PAR-19-286 "Postdoctoral Research Associate Training (PRAT) Program (Fi2)
Notice of Intent to Publish the Reissuance of RFA-CA-18-026, "Improving the Reach and Quality of Cancer Care in
Rural Populations (R01 Clinical Trial Required)" (NOT-CA-19-063)
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional)
(PAR-19-318) – Deadline on rolling basis starting August 26, 2019
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
(RFA-AG-20-010) - October 22, 2019
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
(RFA-AG-20-011) - Deadline October 22, 2019
Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed) (RFA-AG-20-030)
Deadline October 30, 2019
Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21)
(RFA-AT-20-001) – Deadline November 01, 2019
Center of Excellence for Natural Product Drug interaction Research (U54, Clinical Trial Required)
(RFA-AT-20-002) – Deadline November 22, 2019
(Re)Building a Kidney (UC2 Clinical Trial Not Allowed) (RFA-DK-19-007) – Deadline November 7, 2019
Polycystic Kidney Disease Research and Translation Core Centers (U54 Clinical Trial Not Allowed)
(RFA-DK-19-010) - Deadline November 21, 2019
Central Coordinating Site for the Polycystic Kidney Disease Research and Translation Core Centers
(U24 Clinical Trial Not Allowed) (RFA-DK-19-011) – Deadline November 21, 2019
OTHER FEDERAL DEADLINES
National Science Foundation (NSF) - Graduate Research Fellowship Program (GRFP)
Different types of fellowships with their own individual deadlines
BrightFocus Foundation – National Glaucoma Research – Deadline November 8, 2019
The Dickson Prize in Medicine – Deadline October 4, 2019